STOCKWATCH
·
Pharmaceuticals
Board Meeting12 May 2026, 06:31 pm

Albert David: Amit Mahla Appointed CEO, Dividend Recommended

AI Summary

Albert David Ltd's board meeting on May 12, 2026, saw the appointment of Amit Mahla as CEO, effective immediately, following Umesh Manohar Kunte's resignation. The board approved audited financial results for FY26 with an unmodified audit opinion from L. B. Jha & Co. A final dividend of ₹5.00 per share (50%) was recommended, pending shareholder approval at the AGM. The 87th AGM is scheduled for August 6, 2026, with a record date of July 30, 2026. PricewaterhouseCoopers Services LLP and S. Gupta & Co. were re-appointed as Internal Auditors and Cost Auditors, respectively, for FY27.

Key Highlights

  • Amit Mahla appointed as CEO of Albert David Ltd, effective May 12, 2026.
  • Audited Financial Results for FY26 approved with an unmodified audit opinion.
  • Final dividend of ₹5.00 per share (50%) recommended, subject to shareholder approval.
  • 87th Annual General Meeting scheduled for August 6, 2026, via VC/OAVM.
  • PricewaterhouseCoopers Services LLP re-appointed as Internal Auditors for FY27.
ALBERTDA
Pharmaceuticals
ALBERT DAVID LTD.-$

Price Impact